Next Generation News and Research

RSS

Cardionovum to introduce PROLIMUS Biograde system in Europe

Cardionovum GmbH announced today that it expects to launch in Europe in Q4 2012 a next-generation Sirolimus-eluting coronary stent system—PROLIMUS Biograde—which is designed to optimize long-term patient results. Unlike many state-of-the-art DES that are currently being marketed, PROLIMUS Biograde provides multiple pro-healing product features to promote early re-endothelialization.

9 Aug 2012

Study looks at why and to whom people give souvenir gifts

Although it may not seem like much, the small wooden figurine Grandma brought back from the Holy Land has been blessed. She gives the souvenir to her grandchildren knowing she has done her job: deliver God into their lives.

8 Aug 2012

Schizophrenia may be linked to immune function

New Australian research shows that the brains of people with schizophrenia may be under attack by the immune system, providing the strongest evidence to date of a link between immune function and schizophrenia.

7 Aug 2012

Researchers discover genetic cause of type VII mucopolysaccharidosis in Brazilian Terriers

The genetics research group led by Professor Hannes Lohi, based at the University of Helsinki and the Folkh-lsan Research Center, has, in collaboration with Adjunct Professor Kirsi Sainio's research group, discovered the cause of a life-threatening skeletal disorder affecting Brazilian Terriers. The disease is caused by a mutation in the GUSB gene.

7 Aug 2012

Michigan State University to improve food security and nutrition in Africa and Asia

Michigan State University will use a $7.3 million federal grant to cultivate the next generation of agricultural scientists in Africa and Asia, in hopes of improving food security and nutrition there.

7 Aug 2012

Obesity in mothers affects growth of children

Pregnant women who are overweight or obese can encounter a host of health complications. The added weight also appears to affect how their children grow and develop, at least initially.

7 Aug 2012

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

A significant discovery in the development of next-generation antibiotics has been made by Scottish biotechnology company Aquapharm.

6 Aug 2012

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Foundation Medicine, Inc. and Clovis Oncology, Inc. announced today that they have entered into a diagnostic collaboration.

6 Aug 2012

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.

6 Aug 2012

Experts offer disparate views on controlling health care costs

Dueling articles in the New England Journal of Medicine Wednesday propose sharply different ways to curb medical spending. The proposals offer a glimpse of the rival approaches that could emerge in 2013, when Congress will have to tackle the budget deficit and the future of the Medicare program for the elderly and disabled.

3 Aug 2012

Weill Cornell Medical College receives NCATS grant to fund Clinical and Translational Science Center

Weill Cornell Medical College has received $49.6 million from the National Center for Advancing Translational Sciences (NCATS), of the National Institutes of Health (NIH), to fund its Clinical and Translational Science Center (CTSC).

3 Aug 2012

CAP publishes revised version of molecular pathology checklist with dedicated section on NGS

The College of American Pathologists (CAP) published a revised version of its molecular pathology checklist with a dedicated section on next generation sequencing (NGS) as part of the new edition of the CAP Laboratory Accreditation Program checklists released July 31, 2012.

2 Aug 2012

Keeping orphans in communities 'won't end AIDS' but 'will help AIDS orphans'

"The International AIDS Conference [AIDS 2012] was full of talk of hope and best practices, but no one was giving details on how to reach an 'AIDS-free generation,'" GlobalPost correspondent John Donnelly writes in this post in the "Global Pulse" blog.

1 Aug 2012

Gene discovery made for infant-onset blindness

Researchers have discovered that mutations in the NMNAT1 gene encoding nicotinamide mononucleotide adenylyltransferase 1 are present in patients with Leber congenital amaurosis.

1 Aug 2012

Biomimetic bioartificial livers and cell toxicity assays: an interview with Dr. Joris Braspenning, CEO Medicyte

Biomimetic bioartificial livers are liver organoids based on synthetic equivalents of the human extracellular matrix (ECM) which will be seeded with human cells.

1 Aug 2012

Link between maternal metabolic or psychological stress and obesity in offspring

A new report involving mice suggests that a relationship exists between maternal metabolic or psychological stress and the development of obesity, type 2 diabetes, and metabolic syndrome in her offspring. What's more, the report shows that if the stress cannot be reduced or eliminated, manipulating the neuropeptide Y (NPY) system in visceral fat may prevent maternal stress-induced obesity from occurring in the next generation.

1 Aug 2012

FDA clears Reflectance Medical's CareGuide Oximeter

Reflectance Medical, a commercial-stage company focused on the development of physiologic sensors to non-invasively and continuously assess patient metabolic status, announced today that it has received FDA 510(k) clearance for its initial product, the CareGuide Oximeter.

31 Jul 2012

NYGC purchases four Life Technologies' Ion Proton Sequencers

Life Technologies Corporation today announced that the New York Genome Center (NYGC) has purchased four Ion Proton Sequencers for its new Innovation Center.

31 Jul 2012

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).

31 Jul 2012

ATP1A3 gene mutations responsible for alternating hemiplegia of childhood

Alternating hemiplegia of childhood (AHC) is a rare disorder that usually begins in infancy, with intermittent episodes of paralysis and stiffness, first affecting one side of the body, then the other. Symptoms mysteriously appear and disappear, again and again, and affected children often experience dozens of episodes per week. As they get older, children fall progressively behind their peers in both intellectual abilities and motor skills, and more than half develop epilepsy.

31 Jul 2012

Next Generation News and Research

Cardionovum to introduce PROLIMUS Biograde system in Europe

Study looks at why and to whom people give souvenir gifts

Schizophrenia may be linked to immune function

Researchers discover genetic cause of type VII mucopolysaccharidosis in Brazilian Terriers

Michigan State University to improve food security and nutrition in Africa and Asia

Obesity in mothers affects growth of children

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Experts offer disparate views on controlling health care costs

Weill Cornell Medical College receives NCATS grant to fund Clinical and Translational Science Center

CAP publishes revised version of molecular pathology checklist with dedicated section on NGS

Keeping orphans in communities 'won't end AIDS' but 'will help AIDS orphans'

Gene discovery made for infant-onset blindness

Biomimetic bioartificial livers and cell toxicity assays: an interview with Dr. Joris Braspenning, CEO Medicyte

Link between maternal metabolic or psychological stress and obesity in offspring

FDA clears Reflectance Medical's CareGuide Oximeter

NYGC purchases four Life Technologies' Ion Proton Sequencers

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

ATP1A3 gene mutations responsible for alternating hemiplegia of childhood

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News